## Abstract The relative importance of viral tumor antigen expression and the cellular background in the maintenance of a transformation phenotype was examined in five SV40‐transformed teratocarcinoma‐derived cell lines. These cell lines show qualitative differences in growth characteristics associ
Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies
✍ Scribed by Chou-Chik Ting; Dennis Rodrigues; Ronald B. Herberman
- Publisher
- John Wiley and Sons
- Year
- 1973
- Tongue
- French
- Weight
- 343 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The effect of immunization with fetal antigens and tumor‐specific antigens on the transplantation of SVT2, a BALB/c mouse tumor induced by Simian virus 40 (SV40), has been studied. Hyperimmunization with 5,000 R X‐irradiated, syngeneic fetuses of 1–2 weeks' gestation or syngeneic spleen cells gave no protection to SVT2 cell challenge. In contrast, immunization with SV40 or SV40‐transformed cells gave a 100‐ to 1,000‐fold protection. These results gave additional evidence that fetal antigens are different from tumor‐specific transplantation antigen (TSTA).
📜 SIMILAR VOLUMES
Sera from hamsters bearing tumors induced by papovavirus SV40 reacted with tumor antigen prepared either from cells transformed by, or from cells infected with, the homologous virus. Serum titers against both antigens were comparable. A high degree of correlation was obtained with the use of either
Glycolipid extracts were prepared from various Syrian golden hamster cell lines, either SV40-transformed or spontaneously transformed. To detect possible SV40-TSTA activity of the glycolipid preparations. normal hamsten were inoculated with different glycolipid extracts and were subsequently challen
## Abstract The fibrosarcoma ST2, induced by 3‐methylcholan‐threne in BALB/c (H‐2^d^) mice, also expressed alien histocompatibility antigens of the C3Hf and B10 background not encoded by the MHC. To examine the relationship between these alien, minor antigens and the tumor‐specific transplantation